The Valley Desk

NCT04548752 · Interventional trial

Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations

Overall registry status Active not recruiting

Phase 2

Conditions Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov